The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a ...
Pandora’s New Targets Miss Market Views; Launches Buyback
The jeweler’s revenue was up 11% organically compared with the prior-year period, beating consensus, but its outlook for 2025 ...
Cramer's Lighting Round: AbbVie is a buy
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Bridgewater's flagship fund rose 8.2% in January, source says
Bridgewater Associates' flagship fund Pure Alpha posted a gain of 8.2% in January, in a period when investors navigated a ...
No, Mr. President, Canada Doesn’t Prevent U.S. Banks From Operating There
President Donald Trump wrote that Canada “doesn’t even allow U.S. banks to open or do business there.” It isn’t true.
Jim Cramer on Pfizer Inc. (PFE): ‘The Stock Could Soar, Very Little Downside At These Low Levels’
We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...
Jim Cramer on Merck & Co., Inc. (MRK): ‘I Bet The Numbers Will Be Good, But There Are Other Issues’
We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...
Jim Cramer Says ‘I Want You To Sell Viking Therapeutics, Inc. (VKTX) And Roll It Into Viking Holdings’
We recently published an article titled Jim Cramer’s Lightning Rounds: 9 Stocks in Focus. In this article, we are going to ...
Jim Cramer explains how better management can change a stock's fate
CNBC's Jim Cramer on Thursday said Wall Street doesn't focus enough on impressive leaders in the enterprise, suggesting that new CEOs have the power to change a company's valuation in spite of ...
Jim Cramer on Pfizer Inc. (PFE): ‘It’s Too Low To Sell’
We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim Cramer ...
NBC Los Angeles7d
Dow closes more than 150 points higher in volatile session after slew of earnings reports: Live updates
Stocks rose on Thursday, posting gains in a bout of rocky trading as investors weighed the latest earnings from Big Tech companies. Stocks cut gains late in the session after President Donald Trump ...